LEADER 00895nam--2200337---450- 001 990001642340203316 005 20050610093233.0 035 $a000164234 035 $aUSA01000164234 035 $a(ALEPH)000164234USA01 035 $a000164234 100 $a20040507d1958----km-y0itay0103----ba 101 $aspa 102 $aSP 105 $a||||||||001yy 200 1 $a<> afueras$fLuis Goytisolo Gay 210 $aBarcelona$cSeix Barral$d1958 215 $a305 p.$d18 cm 410 0$12001 454 1$12001 461 1$1001-------$12001 700 1$aGOYTISOLO GAY,$bLuis$0561487 801 0$aIT$bsalbc$gISBD 912 $a990001642340203316 951 $aVI.5.A. 114(II sp A 51)$b9160 L.M.$cII sp A 959 $aBK 969 $aUMA 979 $aSIAV5$b10$c20040507$lUSA01$h1535 979 $aCOPAT1$b90$c20050610$lUSA01$h0932 996 $aAfueras$9943192 997 $aUNISA LEADER 05273nam 22007094a 450 001 9911018784503321 005 20200520144314.0 010 $a9786610270941 010 $a9781280270949 010 $a1280270942 010 $a9780470345740 010 $a0470345748 010 $a9780470858370 010 $a0470858370 010 $a9780470014110 010 $a0470014113 035 $a(CKB)1000000000018889 035 $a(EBL)191271 035 $a(SSID)ssj0000221134 035 $a(PQKBManifestationID)11219082 035 $a(PQKBTitleCode)TC0000221134 035 $a(PQKBWorkID)10157824 035 $a(PQKB)11238956 035 $a(MiAaPQ)EBC191271 035 $a(OCoLC)85820303 035 $a(Perlego)2772949 035 $a(EXLCZ)991000000000018889 100 $a20031110d2004 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 00$aPhobias /$feditors, Mario Maj ... [et al.] 210 $aChichester, West Sussex, England ;$aHoboken, NJ $cJ. Wiley$dc2004 215 $a1 online resource (382 p.) 225 1 $aWPA series, evidence and experience in psychiatry ;$vv. 7 300 $aDescription based upon print version of record. 311 08$a9780470858332 311 08$a0470858338 320 $aIncludes bibliographical references and index. 327 $aVOLUME 7 Phobias WPA Series Evidence and Experience in Psychiatry; Contents; List of Review Contributors; Preface; CHAPTER 1 DIAGNOSIS AND CLASSIFICATION OF PHOBIAS; Diagnosis and Classification of Phobias: A Review; COMMENTARIES; 1.1 Two Procrustean or One King-Size Bed for Comorbid Agoraphobia and Panic?; 1.2 Politics and Pathophysiology in the Classification of Phobias; 1.3 A Critical Evaluation of the Classification of Phobias; 1.4 The Role of Spontaneous, Unexpected Panic Attacks in the Diagnosis and Classification of Phobic Disorders; 1.5 Anxiety and Phobia: Issues in Classification 327 $a1.6 Nosology of the Phobias: Clues from the Genome 1.7 Clusters, Comorbidity and Context in Classification of Phobic Disorders; 1.8 Comorbidity in Social Phobia: Nosological Implications; 1.9 Giving Credit to ""Neglected"" or ""Minor"" Disorders; 1.10 A Cognitive Approach to Phobias; 1.11 Diagnosis and Classification of Phobias and Other Anxiety Disorders: Quite Different Categories or Just One Dimension?; CHAPTER 2 EPIDEMIOLOGY OF PHOBIAS; Epidemiology of Phobias: A Review; COMMENTARIES; 2.1 Risk-Factor and Genetic Epidemiology of Phobic Disorders: A Promising Approach 327 $a2.2 Defining a Case for Psychiatric Epidemiology: Threshold, Non-Criterion Symptoms, and Category versus Spectrum 2.3 Phobias: A Difficult Challenge for Epidemiology; 2.4 Phobias: Handy or Handicapping Conditions; 2.5 Phobic Disorders: Can We Integrate Empirical Findings with Clinical Theories?; 2.6 Social Phobia and Bipolar Disorder: The Significance of a Counterintuitive and Neglected Comorbidity; 2.7 Comorbidity between Phobias and Mood Disorders: Diagnostic and Treatment Implications; 2.8 Epidemiology of Phobias: Old Terminology, New Relevance; 2.9 Phobias: Reflections on Definitions 327 $a2.10 Phobias: Facts or Fiction? 2.11 Epidemiology of Phobias: The Pathway to Early Intervention in Anxiety Disorders; CHAPTER 3 PHARMACOTHERAPY OF PHOBIAS; Pharmacotherapy of Phobias: A Review; COMMENTARIES; 3.1 Placing the Pharmacotherapy of Phobic Disorders in a New Neuroscience Context; 3.2 Psychobiology and Pharmacotherapy of Phobias; 3.3 The Neuropsychology of Defence: Implications for Syndromes and Pharmacotherapy; 3.4 Social Phobia: Not Neglected, Just Misunderstood; 3.5 Research in Pharmacotherapy of Social Anxiety Disorder 327 $a3.6 Pharmacotherapy for Phobic Disorders: Where Do We Go from Here? 3.7 Progress in Pharmacotherapy for Social Anxiety Disorder and Agoraphobia; 3.8 Psychopharmacology Treatment of Phobias and Avoidance Reactions; 3.9 Crowning Achievement: The Rise of Anti-phobic Pharmacotherapy; 3.10 Comorbidity and Phobias: Diagnostic and Therapeutic Challenges; 3.11 Comments on the Pharmacotherapy of Agoraphobia; 3.12 Pharmacotherapy of Phobias: A Long-Term Endeavour; 3.13 Behavioural Toxicity of Pharmacotherapeutic Agents Used in Social Phobia 327 $a3.14 Medication Treatment of Phobias: Theories Hide Effectiveness 330 $aPhobias are increasingly common amongst the general population, sometimes resulting in a very significant social disability and burden for the family. Most cases remain undiagnosed, and many of those which are diagnosed are treated inappropriately. Written by internationally renowned psychiatrist, Mario Maj, this book provides an update of research evidence and clinical experience concerning agoraphobia, social phobia and specific phobias. 410 0$aWPA series, evidence and experience in psychiatry ;$vv. 7. 606 $aPhobias 606 $aPhobias$xTreatment 615 0$aPhobias. 615 0$aPhobias$xTreatment. 676 $a616.85/225 701 $aMaj$b Mario$f1953-$0328537 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9911018784503321 996 $aPhobias$94421460 997 $aUNINA